NCT04365530View on ClinicalTrials.gov

Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City

CompletedOBSERVATIONAL
Enrollment

3,767

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

March 6, 2023

Conditions
COVID
Trial Locations (5)

75014

AURA Paris Plaisance, Paris

Fondation Sainte-Marie, Paris

Groupe Hospitalier Paris Saint-Joseph, Paris

Hôpital Bellan, Paris

92350

Hôpital Marie Lannelongue, Le Plessis-Robinson

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT04365530 - Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City | Biotech Hunter | Biotech Hunter